Skip to content

Model 435-02 Cardifix Implantable Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K862276

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK862276 Date2 Jul 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 435-02 Cardifix Implantable Pacing Lead is a Permanent Pacemaker Electrode, classified under product code DTB. This device is designed to deliver electrical stimulation to the heart, ensuring proper cardiac rhythm in patients with bradycardia or conduction disorders by transmitting pacing impulses via an implanted lead system.

Intended for sterile surgical implantation, the Model 435-02 is a single-use device regulated under FDA 510(k) clearance (K862276) as a Class III medical device. It is supplied as a sterile, pre-connected lead for use in cardiac pacing procedures, with no noted MRI safety restrictions. The device was cleared in 1986 and remains authorized for distribution in the United States under the specified registration numbers.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 435-02 Cardifix Implantable Pacing Lead, and how does it function in the body?

    The Model 435-02 Cardifix Implantable Pacing Lead is designed to deliver electrical stimulation to the heart, helping maintain proper cardiac rhythm in patients with bradycardia or conduction disorders. It achieves this by transmitting pacing impulses through an implanted lead system, ensuring consistent electrical signals to regulate heartbeats.

  • Is the Model 435-02 Cardifix Implantable Pacing Lead intended for reuse, or is it meant to be used only once?

    The Model 435-02 Cardifix Implantable Pacing Lead is explicitly labeled as a single-use device. It is supplied sterile and intended for one-time surgical implantation, after which it should not be reused.

  • What are the key details about the regulatory pathway for this device, including its clearance status and classification?

    The Model 435-02 was cleared under FDA 510(k) (K862276) as a Class III medical device in 1986, classified under product code DTB (Permanent Pacemaker Electrode). It was determined substantially equivalent to a predicate device by the FDA’s Cardiovascular (CV) Advisory Committee, following a traditional review process.

  • How is the Model 435-02 Cardifix Implantable Pacing Lead supplied, and what should clinicians consider during storage?

    The device is supplied as a sterile, pre-connected lead, ready for surgical implantation without additional preparation. Since it is single-use, clinicians should store it in its original packaging in a clean, dry environment, away from direct sunlight or extreme temperatures, to preserve sterility and functionality until use.

  • Are there any known restrictions or considerations regarding MRI compatibility for this device?

    The provided data does not mention any MRI safety restrictions for the Model 435-02. However, clinicians should always verify compatibility with their specific MRI system and follow manufacturer guidelines, as pacemaker leads may interact with magnetic fields in unpredictable ways.